Successful clozapine rechallenge following clozapine-induced neuroleptic malignant syndrome

Mental Health Clinician

Volumn 5, Issue 2, 2015, Pages 88-90

  Ross, Clint ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

clozapine; neuroleptic malignant syndrome; rechallenge

Indexed keywords

EID: 85026679097     PISSN: None     EISSN: 21689709     Source Type: Journal    
DOI: 10.9740/mhc.2015.03.088     Document Type: Article

References (14)

1. Velamoor VR. Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Saf. 1998;19(1):73-82. PubMed PMID: 9673859.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. fifth edition. Washington: American Psychiatric Association; 2013.
3. Strawn JR, Keck PE, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870-6. DOI: 10.1176/ajp.2007.164.6.870. PubMed PMID: 17541044.
4. Keyser DL, Rodnitzky RL. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy. Arch Intern Med. 1991;151(4):794-6. PubMed PMID: 1672810.
5. Keck PE, Pope HG, Cohen BM, McElroy SL, Nierenberg AA. Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry. 1989;46(10):914-8. PubMed PMID: 2572206.
6. Susman VL, Addonizio G. Recurrence of neuroleptic malignant syndrome. J Nerv Ment Dis. 1988;176(4):234-41. PubMed PMID: 2895164.
7. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77(1):185-202. PubMed PMID: 8093494.
8. Yacoub A, Francis A. Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam. Neuropsychiatr Dis Treat. 2006;2(2):235-40. PubMed PMID: 19412469.
9. Anbalagan E, Ithman M, Lauriello J. Rechallenging clozapine after neuroleptic malignant syndrome. Psychiatr Q. 2014;85(3):345-8. DOI: 10.1007/s11126-014-9291-9. PubMed PMID: 24633526.
10. Anderson ES, Powers PS. Neuroleptic malignant syndrome associated with clozapine use. J Clin Psychiatry. 1991;52(3):102-4. PubMed PMID: 2005071.
11. Chatterton R, Cardy S, Schramm TM. Neuroleptic malignant syndrome and clozapine monotherapy. Aust N Z J Psychiatry. 1996;30(5):692-3. DOI: 10.3109/00048679609062668. PubMed PMID: 8902179.
12. Goates MG, Escobar JI. An apparent neuroleptic malignant syndrome without extrapyramidal symptoms upon initiation of clozapine therapy: report of a case and results of a clozapine rechallenge. J Clin Psychopharmacol. 1992;12(2):139-40. PubMed PMID: 1573039.
13. Huang TL. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Med J. 2001;24(8):522-5. PubMed PMID: 11601195.
14. Tsai G, Crisostomo G, Rosenblatt ML, Stern TA. Neuroleptic malignant syndrome associated with clozapine treatment. Ann Clin Psychiatry. 1995;7(2):91-5. PubMed PMID: 8556099.